DOXYCYCLINE HYCLATE capsule ABD - İngilizce - NLM (National Library of Medicine)

doxycycline hyclate capsule

apotheca inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate capsules and other antibacterial drugs, doxycycline hyclate capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . - trachoma caused b

NITROFURANTION MACROCRYSTALS capsule ABD - İngilizce - NLM (National Library of Medicine)

nitrofurantion macrocrystals capsule

apotheca inc. - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin macrocrystals is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli, enterococci, staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin macrocrystals and other antibacterial drugs, nitrofurantoin macrocrystals should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other

IBUPROFEN tablet ABD - İngilizce - NLM (National Library of Medicine)

ibuprofen tablet

apotheca inc. - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 200 mg - pain reliever/fever reducer - temporarily relieves minor aches and pains due to: - headache - muscular aches - minor pain or arthritis - toothache - backache - the common cold - menstrual cramps - temporarily reduces fever - if you have ever had an allergic reaction to any other pain reliever/fever reducer - right before or after heart surgery - you feel faint, vomit blood, or have bloody or black stools. these are signs of stomach bleeding. - pain gets worse or lasts more than 10 days - fever gets worse or lasts more than 3 days - stomach pain or upset gets worse or lasts - redness or swelling is present in the painful area - any new symptoms appear

IBUPROFEN- ibuprofen tablet ABD - İngilizce - NLM (National Library of Medicine)

ibuprofen- ibuprofen tablet

apotheca, inc - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 200 mg - pain reliever / fever reducer use(s) temporarily relieves minor aches and pain due to : backache headache menstrual cramps minor pain of arthritis muscular aches the common cold toothache temporarily reduces fever - if you have ever had an allergic reaction to any other pain reliever/fever reducer - right before or after heart surgery

FAMOTIDINE tablet, film coated ABD - İngilizce - NLM (National Library of Medicine)

famotidine tablet, film coated

apotheca inc. - famotidine (unii: 5qzo15j2z8) (famotidine - unii:5qzo15j2z8) - famotidine 20 mg - famotidine tablets usp are indicated in: 1. short-term treatment of active duodenal ulcer most adult patients heal within 4 weeks; there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks. studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than eight weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer controlled studies in adults have not extended beyond one year. 3. short-term treatment of active benign gastric ulcer most adult patients heal within 6 weeks. studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks. 4. short-term treatment of gastroesophageal reflux disease (gerd) famotidine tablets usp are indicated for short-term treatment of patients with symptoms of gerd (see clinical pharmacology in adults , clinical studies ). famotidine tablets are also

LEVOFLOXACIN tablet, film coated ABD - İngilizce - NLM (National Library of Medicine)

levofloxacin tablet, film coated

apotheca inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin tablets, usp and other antibacterial drugs, levofloxacin tablets, usp  should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. levofloxacin tablets, usp are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their suscep

CETIRIZINE HYDROCHLORIDE tablet ABD - İngilizce - NLM (National Library of Medicine)

cetirizine hydrochloride tablet

apotheca inc. - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24) - cetirizine hydrochloride 10 mg - temporarily relieves these symptoms due to hay fever or other upper respiratory allergies - runny nose - sneezing - itchy, watery eyes - itching of the nose or throat if you are taking tranquilizers or sedatives.

ASPIRIN tablet ABD - İngilizce - NLM (National Library of Medicine)

aspirin tablet

apotheca, inc - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 325 g - pain reliever uses: for the temporary relief of minor aches and pains due to: headache, colds, muscle pain, menstrual pain, toothache, minor pain of arthritis or as directed by your doctor. provides temporary relief of - headache - pain and fever of colds - muscle pain - toothache - menstrual pain - minor pain of arthritis.

BENZONATATE capsule, liquid filled ABD - İngilizce - NLM (National Library of Medicine)

benzonatate capsule, liquid filled

apotheca inc. - benzonatate (unii: 5p4dhs6enr) (benzonatate - unii:5p4dhs6enr) - benzonatate 100 mg - benzonatate is indicated for the symptomatic relief of cough. hypersensitivity to benzonatate or related compounds.

PHENAZOPYRIDINE HYDROCHLORIDE- phenazopyridine tablet ABD - İngilizce - NLM (National Library of Medicine)

phenazopyridine hydrochloride- phenazopyridine tablet

apotheca inc. - phenazopyridine hydrochloride (unii: 0ewg668w17) (phenazopyridine - unii:k2j09emj52) - phenazopyridine hydrochloride 200 mg - phenazopyridine hcl is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. the use of phenazopyridine hcl for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. because it provides only symptomatic relief, prompt appropriate treatment of the cause of pain must be instituted and phenazopyridine hcl should be discontinued when symptoms are controlled. the analgesic action may reduce or eliminate the need for systemic analgesics or narcotics. it is, however, compatible with antibacterial therapy and can help to relieve pain and discomfort during the interval before antibacterial therapy controls the infection. treatment of a urinary tract infection with phenazopyridine hcl should not exceed 2 days because there is a lack of evidence that the combined administration of